lswcap
Alphabet, Google’s parent company, announced the launch of Isomorphic Labs, a startup that redevelops the entire drug process from scratch using an AI First approach. DeepMind Demis Hassabis, an artificial intelligence development company known for pioneering AI such as AlphaGo and Alphafold, will take office as CEO of ithermorepic labs.
AI has been in the spotlight recently to help scan databases to find optimal molecules for specific biological targets or to fine-tune optimal compounds, with hundreds of millions of dollars invested in companies developing new drug-related AI tools over 2019-2021. Research results are also available.
Ithermorepic Labs, a startup newly announced by Alphabet, is a company that develops models that can predict how drugs and the human body interact. It is said that they are also considering how to interpret how multiple proteins interact with each other using the knowledge obtained with AlphaFold, a DeepMind protein structure analysis algorithm. Developing drugs in-house is expected to be the content of the business of selling tools that help new drugs to pharmaceutical companies or biomedical companies.
In an article announcing the launch of iThermorepic Labs, CEO Demis Hassabis said that DeepMind has been pioneering AI for more than 10 years, and has been working with passion in the fields of biology and medical research for several years. Biology is considered to be a complex and dynamic information processing system, and he thought that there might be an isomorphic mapping between the two, so he added Isomorphic to the mission.
Although he concurrently serves as the CEO of DeepMind and iThermorepic Labs, the two companies are separate to the last, and he says that they sometimes cooperate. Related information can be found here.
Add comment